Brekenfeld Caspar, Remonda Luca, Nedeltchev Krassen, v Bredow Ferdinand, Ozdoba Christoph, Wiest Roland, Arnold Marcel, Mattle Heinrich P, Schroth Gerhard
Institute of Diagnostic and Interventional Neuroradiology, University of Bern, Inselspital, Switzerland.
Neurol Res. 2005;27 Suppl 1:S29-35. doi: 10.1179/016164105X35549.
Randomized trials have demonstrated the benefit of intra-arterial thrombolysis (IAT) for treatment of acute ischemic stroke, if performed within 6 hours of symptom onset.
We report our experience with 350 acute stroke patients who were treated with IAT using urokinase at a single center. Predictors of favorable outcome were low National Institute of Health Stroke Scale (NIHSS) at admission (p<0.001), good collaterals (p<0.001) and successful endovascular recanalization (p<0.001). Recanalization rates of more than 75% could be achieved, when additional endovascular techniques such as mechanical fragmentation of the thrombus, thromboaspiration, percutaneous transluminal angioplasty, and implantation of stents were used.
Predictors of unfavorable outcome were diabetes mellitus (p<0.001) and symptomatic hemorrhages (p<0.001). The latter occurred in 5% of our population. Preliminary results of new techniques including sonothrombolysis, angiojet aspiration, and laser recanalization of thromboembolic occlusions are discussed.